NANJING, China, May 19, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that its proprietary PD-L1/4-1BB bispecific ...
4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage ...
AstraZeneca’s first foray with PD-L1 inhibitor Imfinzi as a treatment for bladder cancer was a flop. After gaining accelerated approval in the indication in 2017, the company grudgingly clawed back ...
Abstract: This paper presents a geometric analysis of the simultaneous blind deconvolution and phase retrieval (BDPR) problem via a structured low-rank tensor recovery framework. To overcome the ...
# To add your own sources, append them to LV_EDITOR_PROJECT_SOURCES: # list(APPEND LV_EDITOR_PROJECT_SOURCES # ${CMAKE_CURRENT_LIST_DIR}/src/my_widget.c # ${CMAKE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results